Weijun Qin

1.3k citations
66 papers · 881 indexed · h-index 18
Topics
Monoclonal and Polyclonal Antibodies Research (7 papers)Cancer Immunotherapy and Biomarkers (6 papers)Urinary Bladder and Prostate Research (6 papers)
Journals
Angewandte Chemie International EditionSHILAP Revista de lepidopterologíaPLoS ONE

In The Last Decade

Weijun Qin

60 papers receiving 863 citations

Peers

Weijun Qin
Comparison fields: 5 of 107
  • Molecular Biology 270
  • Immunology 187
  • Oncology 140
  • Physiology 115
  • Rheumatology 113
Replace Quan Liu with:
Quan Liu China
Mohamed M. Kamal Egypt
Christian Koppelstaetter Austria
Victor Romanov United States
T Tomoyoshi Japan
Cecilia Johnsson Sweden
Noriyuki Iehara Japan
Akihiro Shimizu Japan
Shin Yamashita Japan
Gerit Theil Germany
Weijun Qin relative to Quan Liu China Quan Liu's profile →
Citations per field
00.5×1.5×2.5×
Quan Liu · 1×
Citations per year

Countries citing papers authored by Weijun Qin

Since Specialization
Citations

This map shows the geographic impact of Weijun Qin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weijun Qin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weijun Qin more than expected).

Fields of papers citing papers by Weijun Qin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weijun Qin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weijun Qin. The network helps show where Weijun Qin may publish in the future.

Co-authorship network of co-authors of Weijun Qin

This figure shows the co-authorship network connecting the top 25 collaborators of Weijun Qin. A scholar is included among the top collaborators of Weijun Qin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weijun Qin. Weijun Qin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 2
4 2
5 1
6 2
7 8
8 1
9 24
10 6
11 17
12 11
13 2
14 35
15 1
16 30
17 8
18 41
19 13
20
Necrosis and apoptosis induced by brucea javanica oil emulsion in bladder cancer cell
3

About Weijun Qin

Weijun Qin is a scholar working on Transplantation, Urology and Endocrine and Autonomic Systems, having authored 66 papers that have together received 881 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (7 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Urinary Bladder and Prostate Research (6 papers). The work is most often cited by research in Urology (73 citations), Nephrology (74 citations) and Transplantation (25 citations). Weijun Qin has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Weihong Wen, Fa Yang, Jianlin Yuan, Fuli Wang, Lijun Yang, Geng Zhang, Donghui Han, Jun Li, Fan Jun and X. Y.. Their work appears in journals such as Angewandte Chemie International Edition, SHILAP Revista de lepidopterología and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026